Investor Presentaiton

Performance Summary Unit: THB, m Q1/2021 Q1/2022 %Chg. SALES REVENUE 119,346 138,887 16% Gross Profit Margin 19.9% 12.8% EBITDA 19,486 13,615 -30% EBITDA Margin 16.3% 9.8% G/L on FV of Biological Assets -74 1,098 1584% Share in Profit of Associates 2,043 -336 -116% NET PROFIT 6,945 2,842 -59% Net Profit Margin 5.8% 2.0% Q1/2022 vs Q1/2021 Revenue continues to grow . Thailand operation up 13%, international operation up 18% Gross profit margin weaken especially from Vietnam • Vietnam swine prices declined YoY Raw material increased partly from Russia-Ukraine situation Share in profit of associates down mainly from weak CTI performance P.9

View entire presentation